Mass Spectrometry Quantification Revealed Accumulation of C-Terminal Fragment of Apolipoprotein E in the Alzheimer's Frontal Cortex

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Wang, Meiyao ^a,b   Turko, Illarion V ^a,b  

^a UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF STANDARDS AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4; NITROGEN 15;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DISEASE SEVERITY; FRONTAL CORTEX; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MASS SPECTROMETRY; NEUROPATHOLOGY; PROTEIN CONTENT; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; TISSUE HOMOGENATE;

ALZHEIMER DISEASE; APOLIPOPROTEIN E4; FRONTAL LOBE; HUMANS; MASS SPECTROMETRY; NITROGEN ISOTOPES; PEPTIDE FRAGMENTS;

EID: 84876150359     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0061498     Document Type: Article

References (19)

1. Weisgraber KH, Rall SC Jr, Mahley RW, (1981) Human E apoprotein heterogeneity. Cysteine-arginine interchanges in the amino acid sequence of the apo-E isoforms. J Biol Chem 256: 9077-9083.
2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
3. Wetterau JR, Aggerbeck LP, Rall SC Jr, Weisgraber KH, (1988) Human apolipoprotein E3 in aqueous solution. I. Evidence for two structural domains. J Biol Chem 263: 6240-6248.
4. Harris FM, Brecht WJ, Xu Q, Tesseur I, Kekonius L, et al. (2003) Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice. Proc Natl Acad Sci USA 100: 10966-1971.
5. Marques MA, Owens PA, Crutcher KA, (2004) Progress toward identification of protease activity involved in proteolysis of apolipoprotein E in human brain. J Mol Neurosci 24: 73-80.
6. Zhou W, Scott SA, Shelton SB, Crutcher KA, (2006) Cathepsin D-mediated proteolysis of apolipoprotein E: possible role in Alzheimer's disease. Neuroscience 143: 689-701.
7. Castano EM, Prelli F, Pras M, Frangione B, (1995) Apolipoprotein E carboxyl-terminal fragments are complexed to amyloids A and L: implications for amyloidogenesis and Alzheimer's disease. J Biol Chem 270: 17610-17615.
8. Marques MA, Tolar M, Harmony JA, Crutcher KA, (1996) A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity. Neuroreport 7: 2529-2532.
9. Huang Y, Liu XQ, Wyss-Coray T, Brecht WJ, Sanan DA, et al. (2001) Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons. Proc Natl Acad Sci USA 98: 8838-8843.
10. Rohn TT, Catlin LW, Coonse KG, Habig JW, (2012) Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brain. Brain Res1475: 106-115.
11. Cho HS, Hyman BT, Greenberg SM, Rebeck GW, (2001) Quantification of apoE domains in Alzheimer disease brain suggests a role for apoE in Abeta aggregation. J Neuropathol Exp Neurol 60: 342-349.
12. Tolar M, Marques MA, Harmony JAK, Crutcher KA, (1997) Neurotoxicity of the 22 kDa thrombin-cleavage fragment of apolipoprotein E and related synthetic peptides is receptor-mediated. J Neurosci 17: 5678-5686.
13. Chang S, Ma TR, Miranda RD, Balestra ME, Mahley RW, et al. (2005) Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity. Proc Natl Acad Sci USA 102: 18694-18699.
14. Bien-Ly N, Andrews-Zwilling Y, Xu Q, Bernardo A, Wang C, et al. (2011) C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-β (Aβ) and acts in concert with Aβ to elicit neuronal and behavioral deficits in mice. Proc Natl Acad Sci USA 108: 4236-4241.
15. Elliott DA, Tsoi K, Holinkova S, Chan SL, Kim WS, et al. (2011) Isoform-specific proteolysis of apolipoprotein-E in the brain. Neurobiol Aging 32: 257-271.
16. Wang M, Chen J, Turko IV, (2012) 15N-Labeled full-length apolipoprotein E4 as an internal standard for mass spectrometry quantification of apolipoprotein E isoforms. Anal Chem 84: 8340-8344.
17. Liao WL, Turko IV, (2008) Strategy combining separation of isotope-labeled unfolded proteins and matrix-assisted laser desorption/ionization mass spectrometry analysis enables quantification of a wide range of serum proteins. Anal Biochem 377: 55-61.
18. Liao WL, Heo GY, Dodder NG, Pikuleva IA, Turko IV, (2010) Optimizing the conditions of a multiple reaction monitoring assay for membrane proteins: quantification of cytochrome P450 11A1 and adrenodoxin reductase in bovine adrenal cortex and retina. Anal Chem 82: 5760-5767.
19. Nilsson J, Ruetschi U, Halim A, Hesse C, Carlsohn E, et al. (2009) Enrichment of glycopeptides for glycan structure and attachment site identification. Nat Methods 6: 809-811.